2024
Preintervention Wait Time and Survival in People With Rheumatic Heart Disease in Uganda
Doh C, An C, Chang A, Rwebembera J, Mwambu T, Beaton A, Nakagaayi D, Ruda Vega P, Sable C, Longenecker C, Lwabi P. Preintervention Wait Time and Survival in People With Rheumatic Heart Disease in Uganda. The Annals Of Thoracic Surgery 2024, 118: 941-948. PMID: 38908768, DOI: 10.1016/j.athoracsur.2024.06.009.Peer-Reviewed Original ResearchRheumatic heart diseaseSurgical interventionRisk factors associated with timeClinical rheumatic heart diseaseFactors associated with timeAtrial fibrillationNew York Heart Association functional class III/IVYears of follow-upHeart diseaseCox proportional hazards modelsHistory of infective endocarditisHistory of atrial fibrillationMultivariate Cox proportional hazards modelFunctional class III/IVPre-interventionRight ventricular dysfunctionProportional hazards modelAssociated with increased probabilityProbability of deathEducation levelKaplan-Meier estimatesSurgical burdenPreoperative mortalityValve surgeryClass III/IV
2023
Abstract 14916: Clinical and Socioeconomic Factors Associated With Time to Surgery and Preoperative Mortality in Surgery-Eligible Patients With Rheumatic Valvular Heart Disease in Uganda
Doh C, An C, Chang A, Rwebembera J, Mwambu T, Beaton A, Nakagaayi D, Vega P, Sable C, Lwabi P, Longenecker C. Abstract 14916: Clinical and Socioeconomic Factors Associated With Time to Surgery and Preoperative Mortality in Surgery-Eligible Patients With Rheumatic Valvular Heart Disease in Uganda. Circulation 2023, 148: a14916-a14916. DOI: 10.1161/circ.148.suppl_1.14916.Peer-Reviewed Original ResearchRheumatic heart diseaseFactors associated with timeLikelihood of surgeryPreoperative mortalitySurgical indicationsAwaiting surgeryAtrial fibrillationIncreased likelihood of surgeryValvular rheumatic heart diseaseHistory of infective endocarditisHistory of atrial fibrillationMultivariate Cox proportional hazards modelAdvanced rheumatic heart diseaseHeart diseaseRate of surgical interventionRheumatic valvular heart diseaseNYHA class I/IISurgery-eligible patientsNYHA class III/IVMedian follow-upAssociated with increased mortalityTime to surgeryCohort of patientsReceipt of surgeryValvular heart disease